Everolimus

NDC 51991-381 · Breckenridge Pharmaceutical, Inc.

Generic nameEverolimus tablets

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength.75 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

51991-381-06 — 60 TABLET in 1 BOTTLE (51991-381-06)

51991-381-60 — 60 BLISTER PACK in 1 CARTON (51991-381-60) / 10 TABLET in 1 BLISTER PACK (51991-381-99)

Billed under HCPCS

J7527 — Everolimus, oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.16

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0245-0822 — Everolimus, 0245-0823 — Everolimus, 0245-0824 — Everolimus, 0245-0825 — Everolimus, 49884-158 — Everolimus, 49884-159 — Everolimus, 49884-160 — Everolimus, 49884-283 — Everolimus, 51991-379 — Everolimus tablets, 51991-380 — Everolimus tablets, 51991-821 — Everolimus, 51991-822 — Everolimus, 51991-823 — Everolimus, 51991-824 — Everolimus, 51991-985 — Everolimus tablets, 51991-990 — Everolimus, 51991-991 — Everolimus, 51991-992 — Everolimus, 59651-931 — everolimus, 59651-932 — everolimus, +63 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.